Gellan Alaa Mohamed Kamel

9PUBLICATIONS
1CO-AUTHORS
Modelling and simulationRehabilitation engineeringCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 12, 2026
Advances in AI's Future in Toxicology: Integrating Computational Prediction and Clinical Translation Through Explainable Artificial Intelligence.

|Jun 08, 2026
Rebamipide attenuates LPS-induced acute lung injury in rats via modulation of macrophage polarization, PDE4B/cAMP/PKA/p-CREB and NF-κB signaling.

|May 22, 2026
Diacerein mitigates cisplatin-induced testicular toxicity in rats; Role of Nrf2/ HO-1, NF-κB/caspase-3 and NLRP3/ASC/Caspase-1 signaling pathways.

|May 09, 2025
Vinpocetine Mitigates Methotrexate-Induced Liver Injury in Rats Through Modulating Intercellular Communication.

Gellan Alaa Mohamed Kamel, Shaimaa Hussein

|Mar 07, 2025
Advancement insights in cancer vaccines: mechanisms, types, and clinical applications.

Gellan Alaa Mohamed Kamel, Rasha A Attia, Hifaa G Al-Noman

|Nov 07, 2023
Pioglitazone attenuates tamoxifen-induced liver damage in rats via modulating Keap1/Nrf2/HO-1 and SIRT1/Notch1 signaling pathways: In-vivo investigations, and molecular docking analysis.

Gellan Alaa Mohamed Kamel, Hemat A Elariny

Pageof 2

Frequent Collaborators

1 joint publications

Hemat A Elariny